FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine and biology, namely to medications, which have heparine-like action. Cyclophiline A-protein with molecular weight 18 kDa in dose 10 mcg/ml has heparine-like action.
EFFECT: invention ensures extension of spectrum of substances with heparine-like action.
4 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| ANTICOAGULATING BIOLOGICALLY ACTIVE COMPLEX MADE OF SIBERIAN CEDAR BARK | 2007 | 
									
  | 
                RU2366441C2 | 
| CYCLOPHILIN A - AGENT ENHANCING THROMBOCYTE ADHESION PROPERTIES | 2010 | 
									
  | 
                RU2435607C1 | 
| METHOD FOR PREPARING HEPARIN WITH LOW MOLECULAR WEIGHT AND ANTICOAGULANT ACTIVITY | 2009 | 
									
  | 
                RU2396282C1 | 
| ANTICOAGULANT | 2009 | 
									
  | 
                RU2399377C1 | 
| ANTITHROMBOTIC AGENT OF SIBERIAN FIR CELLULOSE | 2014 | 
									
  | 
                RU2571555C1 | 
| METHOD FOR MAKING LOW-MOLECULAR HEPARIN | 2007 | 
									
  | 
                RU2377993C2 | 
| SYNTHETIC PEPTIDE DERIVATIVE EXPRESSING ANTICOAGULANT ACTIVITY | 2007 | 
									
  | 
                RU2377246C2 | 
| DOSAGE FORM OF DNA-APTAMER | 2019 | 
									
  | 
                RU2730000C1 | 
| AGENT WITH ANTITHROMBOTIC ACTIVITY | 2016 | 
									
  | 
                RU2627435C1 | 
| DIRECT THROMBIN INHIBITOR, POSSESSING ANTIPROLIFERATIVE ACTION | 2007 | 
									
  | 
                RU2369615C2 | 
Authors
Dates
2011-06-27—Published
2010-04-02—Filed